Syra Health Corp. (NASDAQ:SYRA) Sees Significant Decline in Short Interest

Syra Health Corp. (NASDAQ:SYRAGet Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 728,200 shares, a decline of 16.4% from the February 28th total of 870,700 shares. Based on an average daily volume of 2,110,000 shares, the days-to-cover ratio is presently 0.3 days. Currently, 7.5% of the shares of the company are short sold.

Syra Health Trading Down 37.8 %

Shares of SYRA traded down $0.10 during mid-day trading on Wednesday, hitting $0.17. The company’s stock had a trading volume of 2,681,572 shares, compared to its average volume of 770,734. The firm has a 50-day simple moving average of $0.39 and a 200 day simple moving average of $0.41. Syra Health has a 1-year low of $0.12 and a 1-year high of $2.27. The firm has a market capitalization of $1.90 million, a P/E ratio of -0.26 and a beta of 3.20.

Syra Health (NASDAQ:SYRAGet Free Report) last posted its quarterly earnings results on Tuesday, March 11th. The company reported ($0.05) earnings per share for the quarter. Syra Health had a negative return on equity of 131.94% and a negative net margin of 54.90%. The company had revenue of $2.00 million for the quarter, compared to analyst estimates of $2.01 million. As a group, sell-side analysts predict that Syra Health will post -0.53 EPS for the current fiscal year.

Syra Health Company Profile

(Get Free Report)

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.

Further Reading

Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.